Datzmann et al. assessed some functional renal parameters and structural biomarkers (including NGAL) in people undergoing coronary bypass grafting without showing differences in mortality, acute kidney injury, the need for renal replacement therapy, or evidence of a mechanism for tubular injury [25]. This evidence concerns the gene LCN2 and acute kidney injury.